What is the share price of Brooks Laboratories Ltd (BROOKS) today?
The share price of BROOKS as on 28th March 2025 is ₹106.36. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Brooks Laboratories Ltd (BROOKS) share?
The past returns of Brooks Laboratories Ltd (BROOKS) share are- Past 1 week: -5.38%
- Past 1 month: 5.56%
- Past 3 months: -38.57%
- Past 6 months: -29.33%
- Past 1 year: 13.63%
- Past 3 years: 39.55%
- Past 5 years: 638.01%
What are the peers or stocks similar to Brooks Laboratories Ltd (BROOKS)?
The peers or stocks similar to Brooks Laboratories Ltd (BROOKS) include:What is the market cap of Brooks Laboratories Ltd (BROOKS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brooks Laboratories Ltd (BROOKS) is ₹328.71 Cr as of 28th March 2025.What is the 52 week high and low of Brooks Laboratories Ltd (BROOKS) share?
The 52-week high of Brooks Laboratories Ltd (BROOKS) is ₹198.86 and the 52-week low is ₹73.25.What is the PE and PB ratio of Brooks Laboratories Ltd (BROOKS) stock?
The P/E (price-to-earnings) ratio of Brooks Laboratories Ltd (BROOKS) is -16.79. The P/B (price-to-book) ratio is 5.01.Which sector does Brooks Laboratories Ltd (BROOKS) belong to?
Brooks Laboratories Ltd (BROOKS) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Brooks Laboratories Ltd (BROOKS) shares?
You can directly buy Brooks Laboratories Ltd (BROOKS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Brooks Laboratories Ltd
BROOKS Share Price
106.364.34% (-4.82)
BROOKS Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BROOKS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BROOKS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -16.00 | 5.01 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.27 | 6.30 | 0.54% |
BROOKS Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BROOKS Company Profile
Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.
BROOKS Similar Stocks (Peers)
Compare with peersDIVISLAB
PE Ratio
96.88
1Y Return
67.63%
Buy Reco %
43.48
SYNGENE
PE Ratio
56.68
1Y Return
3.37%
Buy Reco %
75.00
AARTIPHARM
PE Ratio
30.64
1Y Return
72.26%
Buy Reco %
—
PE Ratio
-22.75
1Y Return
7.54%
Buy Reco %
—
VIMTALABS
PE Ratio
56.45
1Y Return
126.32%
Buy Reco %
100.00
BROOKS Forecasts
Price
Revenue
Earnings
BROOKS Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeBROOKS Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeBROOKS Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeBROOKS
Income
Balance Sheet
Cash Flow
Annual Normal View
BROOKS Income Statement
Annual Normal View
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 77.99 | 91.98 | 63.77 | 80.45 | 95.92 | |||||
Raw Materials | 51.77 | 66.28 | 47.45 | 56.59 | 113.16 | |||||
| Power & Fuel Cost | 2.70 | 3.99 | 3.23 | 1.73 | ||||||
| Employee Cost | 12.04 | 16.85 | 16.00 | 10.09 | ||||||
| Selling & Administrative Expenses | 6.21 | 8.57 | 6.21 | 4.05 | ||||||
| Operating & Other expenses | 4.01 | 9.75 | 20.04 | 24.93 | ||||||
EBITDA | 1.26 | -13.46 | -29.16 | -16.94 | -17.24 | |||||
| Depreciation/Amortization | 7.14 | 7.35 | 7.03 | 1.77 | 2.07 | |||||
| PBIT | -5.88 | -20.81 | -36.19 | -18.71 | -19.31 | |||||
| Interest & Other Items | 3.10 | 3.10 | 2.18 | 0.84 | 1.20 | |||||
| PBT | -8.98 | -23.91 | -38.37 | -19.55 | -20.51 | |||||
| Taxes & Other Items | 10.38 | -12.61 | -17.47 | 0.03 | 0.03 | |||||
| Net Income | -19.36 | -11.30 | -20.90 | -19.58 | -20.54 | |||||
| EPS | -7.76 | -4.53 | -8.38 | -7.65 | -7.83 | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BROOKS Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFBROOKS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Brooks Laboratories Ltd | -16.79 | 5.01 | — |
| Divi's Laboratories Ltd | 96.88 | 11.42 | 0.51% |
| Syngene International Ltd | 56.68 | 6.79 | 0.17% |
| Aarti Pharmalabs Ltd | 30.64 | 3.78 | 0.41% |
BROOKS Stock Price Comparison
Compare BROOKS with any stock or ETFCompare BROOKS with any stock or ETF
BROOKS
BROOKS Shareholdings
BROOKS Promoter Holdings Trend
BROOKS Institutional Holdings Trend
No institutional holdings trend are available
BROOKS Shareholding Pattern
BROOKS Shareholding History
Foreign Institutions
Mutual Funds Invested in BROOKS
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
No mutual funds holding trends are available
Top 1 Mutual Funds holding Brooks Laboratories Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 8.7027% | Percentage of the fund’s portfolio invested in the stock 2.46% | Change in the portfolio weight of the stock over the last 3 months 1.54% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/44 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing BROOKS stock
Looks like this stock is not in any smallcase yet.
BROOKS Events
BROOKS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BROOKS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BROOKS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBROOKS Stock News & Opinions
Articles & Videos
Earnings
Brooks Laboratories reports consolidated net loss of Rs 4.57 crore in the December 2024 quarter
Net Loss of Brooks Laboratories reported to Rs 4.57 crore in the quarter ended December 2024 as against net loss of Rs 3.88 crore during the previous quarter ended December 2023. Sales rose 76.78% to Rs 38.45 crore in the quarter ended December 2024 as against Rs 21.75 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales38.4521.75 77 OPM %-8.89-15.49 - PBDT-3.76-3.42 -10 PBT-4.55-3.85 -18 NP-4.57-3.88 -18 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Brooks Laboratories to declare Quarterly Results
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Brooks Laboratories EGM scheduled
Brooks Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 January 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Brooks Laboratories to conduct board meeting
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 11 December 2024Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Brooks Laboratories reports consolidated net loss of Rs 3.96 crore in the September 2024 quarter
Net Loss of Brooks Laboratories reported to Rs 3.96 crore in the quarter ended September 2024 as against net loss of Rs 1.64 crore during the previous quarter ended September 2023. Sales declined 14.51% to Rs 20.79 crore in the quarter ended September 2024 as against Rs 24.32 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales20.7924.32 -15 OPM %-16.40-4.52 - PBDT-3.53-1.20 -194 PBT-3.96-1.64 -141 NP-3.96-1.64 -141 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Brooks Laboratories schedules board meeting
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Brooks Laboratories to conduct AGM
Brooks Laboratories announced that the 22th Annual General Meeting (AGM) of the company will be held on 19 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Brooks Laboratories to hold AGM
Brooks Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 19 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Brooks Laboratories reports consolidated net loss of Rs 2.41 crore in the June 2024 quarter
Net Loss of Brooks Laboratories reported to Rs 2.41 crore in the quarter ended June 2024 as against net loss of Rs 4.47 crore during the previous quarter ended June 2023. Sales rose 14.20% to Rs 17.93 crore in the quarter ended June 2024 as against Rs 15.70 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales17.9315.70 14 OPM %-10.71-24.90 - PBDT-2.01-4.03 50 PBT-2.41-4.47 46 NP-2.41-4.47 46 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Brooks Laboratories schedules board meeting
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Pledged promoter holdings is insignificant